I believe your question is about the difference or the potential benefits around long-acting agents such as an injectable agent versus a daily dispensed medication. Is that correct? Okay.
There is evidence for daily use of OAT medications like buprenorphine and methadone. There is also evidence for long-acting agents like injectable buprenorphine, which is a monthly injectable formulation.
For some people, getting away from taking a medication every day and having that routine as part of their daily experience is beneficial in terms of being able to get away from that idea of continuously taking a medication. They still have access to that medication in their body physiologically, but it's not always front of mind. We have evidence for both, and I think it's important that we have accessibility of a variety of treatment options for people who want to access them, so that we can tailor treatment to the individual in front of us.